Difference between revisions of "Vendor:Medinous, Inc."
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Created as needed.) |
m (Move page script moved page Medinous, Inc. to Vendor:Medinous, Inc. without leaving a redirect) |
Revision as of 19:02, 27 March 2024
Type | Corporation |
---|---|
Industry | Healthcare software |
Headquarters | 200 Metroplex Dr., Ste. 302, Edison, New Jersey, United States |
Number of locations | 2 |
Area served | Worldwide |
Products |
Products list
|
Website | medinous.com |
https://www.linkedin.com/company/medinous/ |
Medinous, Inc. develops and distributes informatics software solutions for hospitals and healthcare facilities.
History
The company was formally founded as a Delaware entity in March 2023.[1]
Technology and products
Medinous Enterprise, Fusion, and Spectrum
Medinous is a modular hospital information system (HIS) that contains a laboratory information system (LIS) module, among other things. The HIS comes in three versions: Fusion, Spectrum, and Enterprise. These version correspond with the size of the medical center or hospital facility. The LIS module is described as providing "a fully optimized, automated diagnostic reporting workflow, starting from test requests raised by physicians, to collection of samples from patients, to processing and reporting of the test results."[2]
Features
The following feature list(s) is/are derived solely from public, freely-available online information the vendor provides. A lack of a "Y" does not necessarily mean that the product doesn't have that feature. The lack of a "Y" could mean:
|
Pricing
Additional information
References
- ↑ "Name Search". Department of State: Division of Corporations. https://icis.corp.delaware.gov/ecorp/entitysearch/NameSearch.aspx. Retrieved 06 June 2023. "File number 7373744"
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 "Streamlined Laboratory Workflow with an Effective Laboratory Information System". Medinous, Inc. https://www.medinous.com/laboratory-information-system.html. Retrieved 06 June 2023.